RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-α secretion

Journal of Lipid Research

Volumn 46, Issue 5, 2005, Pages 1027-1037

  Rouzer, Carol A ^a   Jacobs, Aaron T ^a   Nirodi, Chetan S ^a   Kingsley, Philip J ^a   Morrow, Jason D ^a   Marnett, Lawrence J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Cyclooxygenase 1; Cyclooxygenase 2; Cytosolic phospholipase A2; Lipopolysaccharide; Macrophage

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PRIMER DNA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; AUTOREGULATION; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; ENZYME INDUCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; MACROPHAGE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PROSTAGLANDINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27244448585     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500006-JLR200     Document Type: Article

References (47)

1. Hamberg, M., and B. Samuelsson. 1973. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA. 70: 899-903.
2. Nugteren, D. H., and E. Hazelhof. 1973. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta. 326: 448-461.
3. Hamberg, M., J. Svensson, T. Wakabayashi, and B. Samuelsson. 1974. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA. 71: 345-349.
4. Rouzer, C. A., and L. J. Marnett. 2003. Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem. Rev. 103: 2239-2304.
5. Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69: 145-182.
6. Smith, W. L., R. M. Garavito, and D. L. DeWitt. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271: 33157-33160.
7. Picot, D., P. J. Loll, and R. M. Garavito. 1994. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 367: 243-249.
8. Luong, C., A. Miller, J. Barnett, J. Chow, C. Ramesha, and M. F. Browner. 1996. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat. Struct. Biol. 3: 927-933.
9. Kurumbail, R. G., A. M. Stevens, J. K. Gierse, J. J. McDonald, R. A. Stegeman, J. Y. Pak, D. Gildehaus, J. M. Miyashiro, T. D. Penning, K. Seibert, P. C. Isakson, and W. C. Stallings. 1996. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 384: 644-648.
10. Laneuville, O., D. K. Breuer, N. Xu, Z. H. Huang, D. A. Gage, J. T. Watson, M. Lagarde, D. L. DeWitt, and W. L. Smith. 1995. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z,13E/Z,15Z)-octadecatrienoic acids from alpha-linolenic acid. J. Biol. Chem. 270: 19330-19336.
11. 2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272: 21181-21186.
12. Kozak, K. R., S. W. Rowlinson, and L. J. Marnett. 2000. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem. 275: 33744-33749.
13. Kozak, K. R., J. J. Prusakiewicz, S. W. Rowlinson, D. R. Prudhomme, and L. J. Marnett. 2003. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. Biochemistry. 42: 9041-9049.
14. Chen, W., T. R. Pawelek, and R. J. Kulmacz. 1999. Hydroperoxide dependence and cooperative cyclooxygenase kinetics in prostaglandin H synthase-1 and -2. J. Biol. Chem. 274: 20301-20306.
15. Guo, Q., L. H. Wang, K. H. Ruan, and R. J. Kulmacz. 1996. Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents. J. Biol. Chem. 271: 19134-19139.
16. Greig, G. M., D. A. Francis, J. P. Falgueyret, M. Ouellet, M. D. Percival, P. Roy, C. Bayly, J. A. Mancini, and G. P. O'Neill. 1997. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. Mol. Pharmacol. 52: 829-838.
17. Rieke, C. J., A. M. Mulichak, R. M. Garavito, and W. L. Smith. 1999. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors. J. Biol. Chem. 274: 17109-17114.
18. Kalgutkar, A. S., B. C. Crews, S. W. Rowlinson, A. B. Marnett, K. R. Kozak, R. P. Remmel, and L. J. Marnett. 2000. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Proc. Natl. Acad. Sci. USA. 97: 925-930.
19. Xie, W. L., J. G. Chipman, D. L. Robertson, R. L. Erikson, and D. L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA. 88: 2692-2696.
20. Kujubu, D. A., B. S. Fletcher, B. C. Varnum, R. W. Lim, and H. R. Herschman. 1991. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266: 12866-12872.
21. O'Banion, M. K., V. D. Winn, and D. A. Young. 1992. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA. 89: 4888-4892.
22. Hla, T., and K. Neilson. 1992. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA. 89: 7384-7388.
23. Herschman, H. R. 1996. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1299: 125-140.
24. Rouzer, C. A., P. J. Kingsley, H. Wang, H. Zhang, J. D. Morrow, S. K. Dey, and L. J. Marnett. 2004. Cyclooxygenase-1-dependent prostaglandin synthesis modulates tumor necrosis factor-alpha secretion in lipopolysaccharide- challenged murine resident peritoneal macrophages. J. Biol. Chem. 279: 34256-34268.
25. Raschke, W. C., S. Baird, P. Ralph, and I. Nakoinz. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell. 15: 261-267.
26. DuBois, R. N., J. Awad, J. Morrow, L. J. Roberts 2nd, and P. R. Bishop. 1994. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J. Clin. Invest. 93: 493-498.
27. + coordination tandem mass spectrometry. Anal. Biochem. 314: 8-15.
28. Kampfer, H., L. Brautigam, G. Geisslinger, J. Pfeilschifter, and S. Frank. 2003. Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. J. Invest. Dermatol. 120: 880-890.
29. 2-induced suppression. J. Immunol. 142: 4346-4350.
30. 2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. J. Leukoc. Biol. 45: 416-421.
31. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263: 5380-5384.
32. Taffet, S. M., K. J. Singhel, J. F. Overholtzer, and S. A. Shurtleff. 1989. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell. Immunol. 120: 291-300.
33. Tsuboi, K., Y. Sugimoto, and A. Ichikawa. 2002. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat. 68-69: 535-556.
34. Hata, A. N., and R. M. Breyer. 2004. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103: 147-166.
35. Hirabayashi, T., and T. Shimizu. 2000. Localization and regulation of cytosolic phospholipase A(2). Biochim. Biophys. Acta. 1488: 124-138.
36. 2 activation. J. Leukoc. Biol. 65: 330-336.
37. 2 in eicosanoid generation. Am. J. Respir. Crit. Care Med. 161 (Suppl.): 32-35.
38. 2 regulation. J. Biol. Chem. 275: 20146-20156.
39. 2 in allergic response and parturition. Nature. 390: 618-622.
40. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. USA. 96: 4803-4807.
41. 2. Nature. 390: 622-625.
42. 2 synthesis in mouse osteoblasts cultured with interleukin-1. J. Biol. Chem. 272: 5952-5958.
43. 2. Cell. Signal. 14: 199-204.
44. Balsinde, J., M. A. Balboa, and E. A. Dennis. 2000. Identification of a third pathway for arachidonic acid mobilization and prostaglandin production in activated P388D1 macrophage-like cells. J. Biol. Chem. 275: 22544-22549.
45. Scott, W. A., N. A. Pawlowski, H. W. Murray, M. Andreach, J. Zrike, and Z. A. Cohn. 1982. Regulation of arachidonic acid metabolism by macrophage activation. J. Exp. Med. 155: 1148-1160.
46. Humes, J. L., S. Burger, M. Galavage, F. A. Kuehl, Jr., P. D. Wightman, M. E. Dahlgren, P. Davies, and R. J. Bonney. 1980. The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms. J. Immunol. 124: 2110-2116.
47. 2 in resident and thioglycollate-elicited macrophages in rats. Prostaglandins Other Lipid Mediat. 56: 7-18.